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Abstract
AIM: To investigate the potential associations among 
major depression, quality of life, and suicidal behavior 
in human immunodeficiency virus (HIV) patients. 
METHODS: A detailed MEDLINE search was carried 
out to identify all articles and book chapters in English 
published from January 1995 to January 2015. 
RESULTS: Based on the main findings, the prevalence of 
major depressive disorder (MDD) ranged from 14.0% to 
27.2%. Furthermore, the prevalence of suicidal ideation 
varied from 13.6% to 31.0% whereas, attempted 
suicides were reported to range from 3.9% to 32.7%. 
Interestingly, various associated risk factors for both 
depression and suicide were identified in HIV patients. 
Finally, consistent associations were reported among 
MDD, suicidal ideation, and poor quality of life in indi-
viduals living with HIV. 
CONCLUSION: Although additional studies are needed 
to elucidate this complex association, our results suggest 
the importance of early detection of both MDD and 
suicidality in patients living with HIV.
Key words: Major depression; Suicidal behavior; Quality 
of life; Human immunodeficiency virus infection
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Core tip: Among patients with human immunodeficiency 
virus (HIV) the prevalence of major depressive disorder 
(MDD), suicidal ideation, and attempted suicides 
ranged from 14.0% to 27.2%, from 13.6% to 31.0%, 
and from 3.9% to 32.7%, respectively. Multiple risk 
factors for both depression and suicide were identified 
in HIV patients. Importantly, a consistent association 
has been reported between MDD, suicidal ideation, and 
poor quality of life in individuals living with HIV. The 
early detection and adequate treatment of depressive 
symptoms and suicidality should be considered funda-
mental tasks when managing HIV infected patients, 
particularly in those individuals who are severely 
medically ill.
Serafini G, Montebovi F, Lamis DA, Erbuto D, Girardi P, Amore 
M, Pompili M. Associations among depression, suicidal behavior, 
and quality of life in patients with human immunodeficiency 
virus. World J Virol 2015; 4(3): 303-312  Available from: URL: 
http://www.wjgnet.com/2220-3249/full/v4/i3/303.htm  DOI: 
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INTRODUCTION
Chronic medical conditions such as human immunode­
ficiency virus (HIV) infection have been found to be 
associated with elevated stigma and discrimination, 
psychological distress, and poor social support[1]. Almost 
half of individuals diagnosed with HIV suffer from one or 
more comorbid psychiatric disorders[2] and experience 
a poorer health­related quality of life compared to 
individuals without comorbidities[3].
Major depressive disorder (MDD) is a highly comorbid 
psychiatric condition in patients with HIV, and the presence 
of MDD is associated with poor adherence to treatment, 
disease progression, and lower quality of life[4]. It has been 
well established that depressive symptoms may contribute 
to both HIV progression and mortality[5]. For example, 
in a 7­year longitudinal study, Ickovics et al[6] found that 
women with HIV and chronic depressive symptoms had 
twice the risk of dying by suicide compared to those with 
few or no depressive symptoms. Specifically, the mortality 
rates were 54% among patients with chronic depressive 
symptoms and 48% among those with intermittent 
depressive symptoms as compared to 21% for women 
having few or no depressive symptoms and low CD4 cell 
counts[6]. MDD is also associated with premature drop­
out and poorer outcomes after treatment[7,8], as well as 
persistent drug use in heroin users[9].
In addition to depression, suicidality, which includes 
both suicide ideation and attempts, is considered to 
be another major psychiatric problem associated with 
HIV/acquired immune deficiency syndrome (AIDS)[10]. 
Similar to MDD, an association between suicidality, poor 
quality of life, poor adherence to antiretroviral therapy, 
and non­disclosure of HIV status to significant others 
has been also reported[10,11]. Overall, socio­demographic 
variables (e.g., female gender, younger age); psychiatric 
conditions such as substance abuse, MDD, and a history 
of prior suicide attempts; neuropsychiatric side­effects 
of antiretroviral therapy and psychotropic medication; 
psychosocial factors including heterosexual orientation, 
poor social support, loss of employment, maltreatment, 
and sexual abuse; and clinical factors (e.g., stress 
reactions, the perception of pain, physical impairment, 
psychological/physical symptoms, and AIDS diagnosis) 
have been found to contribute to suicidality among HIV 
patients[12­19].
Thus, individuals with HIV infection may have a higher 
risk of suicide than those individuals without HIV[20­22]. In 
addition, many individuals living with HIV are reluctant to 
disclose their HIV serostatus to friends and/or family due 
to the fear of stigmatization[23,24]. Moreover, individuals who 
experience this type of fear may have disadvantages with 
regards to seeking HIV testing, education, or treatment[25]. 
Interestingly, the introduction of antiretroviral medi­
cations significantly improved both HIV health­outcomes 
and life expectancy of HIV infected patients, which led to a 
significant reduction of suicide rates[26]. However, patients 
living with HIV/AIDS are still dying in large numbers and, 
therefore, examining quality­of­life issues remains an 
important area of research[27]. In particular, individuals 
with HIV reported profound alterations in day­to­day 
activities, significant relationships, and health status[28]. 
Accordingly, several psychometric instruments and 
health questionnaires have been specifically developed to 
evaluate quality of life among individuals with HIV. 
Based on the current literature, it remains unclear 
whether or not individuals with HIV and poor quality of life 
are at a higher risk of depression/suicidality than those 
with HIV and a higher quality of life. Thus, the present 
review aimed to investigate the nature of the associations 
between MDD, quality of life, and suicidal behavior in HIV 
patients.
MATERIALS AND METHODS
In order to provide a critical review of the associations 
among depression, suicidality, and quality of life among 
patients with HIV infection, we performed a detailed 
search using the largest existing databases (PubMed/
MEDLINE, Scopus, Web of Science, and Psychinfo) to 
identify all articles and book chapters in English published 
between January 1995 and January 2015. Specifically, 
the following search terms were used: “Major depression” 
OR “Major Depressive Disorder” OR “MDD” AND “Suicidal 
Behavior” OR “Suicide attempts” OR “Suicide ideation” 
OR “suicidality” AND “Quality of life” AND “HIV infection.” 
Full­text articles were evaluated for relevance when a 
title or abstract appeared to describe a study eligible for 
inclusion. Abstracts that did not explicitly mention the 
association between depression, suicidality, and quality 
of life among individuals living with HIV were excluded. 
We also excluded meta­analytic studies and reviews. 
Overall, we identified 36 articles; however, only 12 full-
text articles included in our review.
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Study design and eligibility criteria
To achieve a high standard of reporting, we have adopted 
Preferred Reporting Items for Systematic Reviews and 
Meta­Analyses’ (PRISMA) guidelines[29]. The PRISMA 
Statement consists of a 27­item checklist and a four­
phase flow diagram for reporting in systematic reviews. 
PRISMA includes the broader effort to improve the 
reporting of different types of health research as well 
as to improve the quality of research used in decision­
making in healthcare.
RESULTS
Number of studies selected
The combined search strategy yielded a total of eighty 
articles of which, after a complete analysis, twenty­
eight full-text articles were screened and fifty-two were 
excluded. We excluded articles that were not published 
in peer reviewed journals, those that were not in English 
language, articles without abstracts, abstracts that did not 
explicitly refer to the main topic, and those with unclear 
data regarding materials and methods and subjects 
which were analyzed. We assessed fourteen articles for 
eligibility but two full­text articles were excluded due 
to low­relevance to the main theme. Therefore, twelve 
articles fulfilled our inclusion criteria and were included in 
the present review (Figure 1).
Type of studies selected
Studies that investigated the prevalence of 
depression, suicide ideation, suicide thoughts, in 
patients living with HIV: Nine studies investigated the 
prevalence of suicide ideation/thoughts and associated 
risk factors in HIV infected patients. Ogundipe et al[30] 
found that 13.6% of 295 people living with HIV/AIDS 
(PLWHA) reported suicidal ideation. 
Moreover, Kinyanda et al[31] demonstrated that the 
prevalence of moderate to high risk for suicidality (MHS) 
and lifetime suicide attempts of 618 recruited patients 
was 7.8% and 3.9%, respectively. 
In a sample of 62 randomly selected HIV+ women, 
Lewis et al[32] investigated the existence and impact of 
major depression. The researchers also found that activities 
of daily living (ADL) and the subjective questionnaire of 
cognitive functioning were useful instruments to assess 
depression. 
In another study, the clinical/behavioral characteristics 
of 71 patients in northern Taiwan as related to their HIV 
status have been explored by Lee et al[33]. Based on the 
main findings, anxiety was reported in 21.0% of patients, 
depression in 27.2%, memory alterations in 32.7%, and 
suicide attempts in 32.7%. Atkinson et al[34] also reported 
that HIV+ individuals (N = 203) reported a significantly 
higher rate of lifetime MDD than HIV­ participants (14% 
vs 5%). However, both HIV+ and HIV­ reported similar 
rates of current MDD.
Furthermore, Sherr et al[11] demonstrated that the 
prevalence of suicidal ideation was 31% in a sample of 
778 patients living with HIV. Interestingly, heterosexual 
men and black respondents were twice as likely to 
experience suicidal ideation when compared to gay men 
or women and White/Asian respondents. In addition, 
individuals who did not disclose their HIV status were 
twice as likely to report suicidal ideation as compared to 
other subjects.
In another study conducted in a sample of 28 Chinese 
HIV+ participants and 23 matched HIV­ controls, nearly 
79% of HIV infected individuals had a significantly higher 
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27 records identified through 
MEDLINE/PubMed searching 
53 (4 + 9 + 40) additional records identified through 
other sources (Web of Science, Scopus, Psychinfo)
75 records after duplicates removed 
28 records screened 47 records excluded
14 full-text articles assessed for 
eligibility 
14 full-text articles excluded with 
reasons
2 studies excluded with reasons 12 studies included in qualitative 
synthesis 
Included
Eligibility
Screening
Identification
Figure 1  Flowchart of the search and selection process.
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Evaluation of Memphis, Pisa, Paris and San Diego­
self administered version (TEMPS­A) were reported 
in patients with a poorer HRQoL relative to those with 
higher HRQoL. Furthermore, Atkinson et al[34] reported 
that 203 HIV+ were more likely to have a lifetime 
substance use diagnoses than HIV­ participants (14% vs 
6%). They also found that worse daily functioning and 
life quality as well as unemployment were independently 
predicted by both depression and HIV status.
Palliative care and quality­of­life issues are still two 
relevant areas of research in patients with advanced 
AIDS. Breitbart et al[39] investigated the impact of 
treatment for depression on the desire for hastened 
death in a sample of 372 patients with advanced AIDS. 
They reported a significant association between desire for 
death and depression; also, desire for death was reduced 
in those patients who responded to antidepressants 
medications. However, nearly half of those individuals 
who received antidepressant medications and/or 
supportive psychotherapy or counseling showed little or 
no improvement in depressive symptoms. In another 
study, Jin et al[35] found that worse daily functioning was 
independently predicted by both major depression and 
HIV+ status in a sample of 28 Chinese HIV+ participants 
and 23 matched HIV­ controls.
Furthermore, in a sample of HIV­infected women 
directly after diagnosis, Krabbendam et al[40] found that 
the women experienced strong emotions and quality of 
life impairment, suggesting that high emotional distress 
may be occurred in specific phases of HIV illness. In 
addition, Haller and Miles[36] demonstrated a significant 
association between quality of life variables and suicide 
ideation in 190 HIV patients. Specifically, leisure/social 
and family/friends were strongly associated with suicidal 
ideation in their sample. Finally, higher emotional distress 
together with poorer HRQoL were found in a sample of 
individuals living with HIV­AIDS (N = 113) who reported 
suicide thoughts as compared to those who had not 
considered suicide[37] (Tables 1 and 2).
DISCUSSION
The present mini­review aimed to investigate the associ­
ations among MDD, quality of life, and suicidal behavior.
First, our findings indicated that the prevalence of 
a current MDD diagnosis varied from 14.0% to 27.2% 
according to the selected samples[33,34]; however, 
as high as 79% of HIV patients reported a lifetime 
diagnosis of MDD[35]; Second, the prevalence of suicidal 
ideation ranged from 13.6% to 31.0%; whereas, the 
prevalence of attempted suicide ranged from 3.9% to 
32.7%[11,30,31,33]; Third, various associated risk factors for 
depression and suicide were found to be important in HIV 
patients[11,30,31,33,36,37].
Other recent studies[41­43] confirmed this high but more 
variable prevalence of MDD in HIV patients ranging between 
18% to 81% at some stage of the illness according to 
the different populations which were investigated, the 
different study designs as well as the  different diagnostic 
lifetime rate of major depression relative to 4% of the 
comparison group[35]. Moreover, 18% of these patients 
reported active suicidal thoughts. 
Haller and Miles[36] also examined suicidality among 
190 HIV+ participants and reported that 26% had 
suicidal thoughts within 30 d of hospitalization, 49% 
revealed that they had a suicide plan, and 48% indicated 
they had suicide intent. Further, individuals with suicidal 
ideation had predominantly MDD (64%). 
Finally, Kalichman et al[37] found that in a sample of 
individuals aged 45 or older and living with HIV/AIDS (N = 
113), 27% reported suicidal thoughts. 
Studies that investigated the associated risk 
factors in patients living with HIV: Six studies 
investigated the relevance of associated risk factors 
in HIV infected patients. Ogundipe et al[30] identified 
unemployment, emotional distress, religion, HIV 
status non­disclosure, and previous suicidal attempt as 
significant predictors of suicidal ideation in their sample. 
In another study, Kinyanda et al[31] reported that significant 
unique predictors of MHS included female gender, 
increasing negative life events, a previous psychiatric 
history, and MDD.
Other articles focused on the importance of associated 
risk factors in patients diagnosed with HIV. For example, 
sexual intercourse without condoms during the six 
previous months were found more frequently in HIV­
negative heroin users compared to HIV­positive heroin 
users[33] whereas higher levels of physical and psychol­
ogical symptoms independently predicted suicidal 
ideation[11].
Furthermore, Haller and Miles[36] suggested that 
individuals with MDD, dysthymia, substance abuse, 
thought disorders, post­traumatic stress disorder (PTSD), 
or borderline/avoidant personality disorders were more 
likely to report suicidality. 
Interestingly, subjects with suicidal thoughts 
more frequently used escape and avoidance whereas 
positive­reappraisal coping strategies were used less 
frequently[37]. The authors[37] demonstrated the existence 
of associations among suicidal thoughts and perceived 
poor social support from friends/family even after 
controlling for depression.
Studies that analyzed the association between 
depression, suicidality and quality of life in HIV 
patients: Eight of the included studies examined the 
associations between depression, suicidality and quality 
of life in samples of HIV patients. First, a significant 
association between suicidal ideation and being 
unmarried, poor medication and quality of life was found 
by Ogundipe et al[30] in a sample of 295 PLWHA.
Furthermore, Pompili et al[38] reported that HIV 
patients with a poorer health­related quality of life 
(HRQoL) had higher hopelessness levels (these subjects 
were at high suicide risk) and were more likely to have 
depression than those with a higher HRQoL. In addition, 
higher scores on all dimensions of the Temperament 
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ro
ss
-s
ec
tio
na
l n
at
ur
e 
of
 th
e 
st
ud
y;
 (2
) t
he
 s
m
al
l n
um
be
r o
f s
ub
je
ct
s 
w
ith
 s
om
e 
of
 th
e 
di
ag
no
se
d 
ps
yc
hi
at
ri
c 
di
so
rd
er
s;
 (3
) t
he
 th
re
sh
ol
d 
as
 a
 c
ut
-o
ff 
po
in
t f
or
 M
H
S 
ha
s 
be
en
 n
ot
 v
al
id
at
ed
 
in
 th
e 
A
fr
ic
an
 s
oc
io
-c
ul
tu
ra
l c
on
te
xt
; 
(4
) t
he
 u
se
 o
f t
he
 “
ri
sk
 fo
r s
ui
ci
da
lit
y”
 
m
ea
su
re
 in
st
ea
d 
of
 “
su
ic
id
al
ity
”
Bo
th
 s
oc
ia
l a
nd
 p
sy
ch
ol
og
ic
al
 
st
re
ss
or
s 
m
ay
 a
ct
 o
n 
pr
ev
io
us
 a
nd
 
cu
rr
en
t p
sy
ch
ia
tr
ic
 m
or
bi
di
tie
s 
tr
ig
ge
ri
ng
 s
ui
ci
da
lit
y
Le
w
is
 et
 a
l[3
2]
C
ro
ss
-s
ec
tio
na
l 
st
ud
y
62
 H
IV
-p
os
iti
ve
 
w
om
en
 (m
ea
n 
ag
e 
35
.7
 ±
 6
.6
 y
r)
N
o
BD
I-F
S,
 M
M
 o
f 
th
e 
Pr
im
ar
y 
C
ar
e 
Ev
al
ua
tio
n 
of
 M
en
ta
l 
D
is
or
de
rs
, A
D
L,
 a
nd
 
SC
Q
A
D
L 
an
d 
su
bj
ec
tiv
e 
qu
es
tio
nn
ai
re
 o
f c
og
ni
tiv
e 
fu
nc
tio
ni
ng
 w
er
e 
us
ef
ul
 in
st
ru
m
en
ts
 to
 m
ea
su
re
 
de
pr
es
si
on
 in
 H
IV
-p
os
iti
ve
 w
om
en
(1
) T
he
 c
ro
ss
-s
ec
tio
na
l n
at
ur
e 
of
 th
e 
pr
es
en
t d
at
a;
 (2
) T
he
 s
m
al
l s
am
pl
e 
si
ze
 
w
hi
ch
 m
ay
 li
m
it 
th
e 
ge
ne
ra
liz
at
io
n 
of
 
fi
n
d
in
gs
; (
3)
 P
ar
ti
ci
p
an
ts
 h
av
e 
be
en
 n
ot
 
ev
al
ua
te
d 
du
rin
g 
a 
fo
llo
w
-u
p 
pe
rio
d;
 (4
) 
th
e 
sa
m
pl
e 
in
cl
ud
es
 o
nl
y 
w
om
en
 
D
ia
gn
os
is
 o
f d
ep
re
ss
io
n 
is
 o
f g
re
at
 
im
po
rt
an
ce
, n
ot
 o
nl
y 
cl
in
ic
al
ly
, b
ut
 
al
so
 to
 e
ns
ur
e 
th
e 
ju
di
ci
ou
s 
al
lo
ca
tio
n 
of
 s
ca
rc
e 
m
ed
ic
al
 re
so
ur
ce
s 
in
 th
e 
re
gi
on
s 
w
or
st
 a
ffe
ct
ed
 b
y 
H
IV
Le
e 
et
 a
l[3
3]
C
ro
ss
-s
ec
tio
na
l 
st
ud
y
57
6 
pa
tie
nt
s 
(5
03
 
m
al
e,
 7
3 
fe
m
al
e;
 
m
ea
n 
ag
e 
40
.6
 ±
 
9.
3 
yr
) o
f w
hi
ch
 
71
 w
er
e 
H
IV
 
po
si
tiv
e,
 a
nd
 5
14
 
ha
d 
he
pa
tit
is
 C
N
o
A
 s
em
i-s
tr
uc
tu
re
d 
qu
es
tio
nn
ai
re
 a
ss
es
si
ng
 
de
m
og
ra
ph
ic
s,
 
qu
al
ity
 o
f l
ife
, 
H
IV
 ri
sk
 b
eh
av
io
r, 
an
d 
ps
yc
hi
at
ri
c 
sy
m
pt
om
s,
an
d 
W
H
O
Q
O
L-
BR
EF
O
ve
ra
ll,
 2
1.
0%
 o
f t
he
 s
ub
je
ct
s 
re
po
rt
ed
 a
nx
ie
ty
, 
27
.2
%
 d
ep
re
ss
io
n,
 3
2.
7%
 m
em
or
y 
lo
ss
, a
nd
 3
2.
7%
 
at
te
m
p
te
d
 s
u
ic
id
e.
 B
as
ed
 o
n
 th
e 
m
ai
n
 fi
n
d
in
gs
, H
IV
-
ne
ga
tiv
e 
he
ro
in
 u
se
rs
 w
er
e 
m
or
e 
lik
el
y 
to
 h
av
e 
se
xu
al
 
in
te
rc
ou
rs
e 
w
ith
ou
t c
on
do
m
s 
du
ri
ng
 th
e 
si
x 
pr
ev
io
us
 
m
on
th
s
(1
) T
he
 s
am
pl
e 
m
ay
 b
e 
no
t 
re
pr
es
en
ta
tiv
e 
of
 th
e 
Ta
iw
an
es
e 
he
ro
in
 
us
er
s p
op
ul
at
io
n;
 (2
) I
t w
as
 n
ot
 p
os
si
bl
e 
to
 v
al
id
at
e 
w
he
th
er
 p
at
ie
nt
s 
re
pl
ie
d 
th
e 
qu
es
tio
ns
 tr
ut
hf
ul
ly
N
o 
si
gn
ifi
ca
n
t d
if
fe
re
n
ce
s 
w
er
e 
fo
u
n
d
 
be
tw
ee
n 
th
e 
H
IV
-p
os
iti
ve
 a
nd
 H
IV
-
ne
ga
tiv
e 
pa
tie
nt
s 
on
 p
sy
ch
ia
tr
ic
 
sy
m
pt
om
s 
or
 q
ua
lit
y 
of
 li
fe
Serafini G et al . Depression, suicide, HIV infection
cr
ite
ria
 w
hi
ch
 w
er
e 
us
ed
. 
A
s 
re
po
rt
ed
 b
y 
H
irs
ch
 A
lle
n 
et
 a
l[4
4]
, d
ep
re
ss
io
n 
m
ay
 b
e 
ev
al
ua
te
d 
bo
th
 d
im
en
si
on
al
ly
 a
s 
w
el
l a
s 
ca
te
go
ric
al
ly
 a
nd
 th
is
 is
 th
e 
fir
st
 s
ou
rc
e 
of
 v
ar
ia
bi
lit
y.
 
In
 a
dd
iti
on
, 
M
D
D
 in
 H
IV
 p
at
ie
nt
s 
m
ay
 v
ar
y 
ac
co
rd
in
g 
to
 s
ev
er
al
 v
ar
ia
bl
es
 s
uc
h 
as
 t
he
 p
op
ul
at
io
n 
of
 in
te
re
st
, 
m
ai
n 
re
se
ar
ch
 h
yp
ot
he
se
s 
as
 w
el
l a
s 
co
m
pa
ris
on
s 
w
ith
 o
th
er
 
st
ud
ie
s/
po
pu
la
tio
ns
. 
Im
po
rt
an
tly
, 
de
pr
es
si
ve
 s
ym
pt
om
s 
th
at
 d
o 
no
t 
m
ee
t 
di
ag
no
st
ic
 c
rit
er
ia
 m
ay
 b
e 
al
so
 a
ss
oc
ia
te
d 
w
ith
 s
ig
ni
fic
an
t 
ps
yc
ho
so
ci
al
 im
pa
irm
en
t 
an
d 
di
sa
bi
lit
y[
44
] . 
M
or
eo
ve
r, 
th
e 
ro
le
 o
f 
so
m
at
ic
 s
ym
pt
om
s 
re
la
te
d 
to
 d
ep
re
ss
io
n 
m
ay
 b
e 
fr
eq
ue
nt
ly
 n
eg
le
ct
ed
 in
 H
IV
 in
fe
ct
ed
 p
at
ie
nt
s 
du
e 
to
 t
he
ir 
fr
eq
ue
nt
 o
ve
rla
pp
in
g 
w
ith
 s
om
at
ic
 c
om
pl
ai
nt
s 
di
re
ct
ly
 r
el
at
ed
 t
o 
th
e 
di
se
as
e.
 
O
ve
ra
ll,
 c
lin
ic
ia
ns
 s
ho
ul
d 
ca
re
fu
lly
 c
on
si
de
r 
th
at
 s
cr
ee
ni
ng
, 
di
ag
no
si
ng
, 
an
d 
qu
an
tif
yi
ng
 d
ep
re
ss
iv
e 
sy
m
pt
om
s 
re
pr
es
en
t 
th
re
e 
di
ffe
re
nt
 b
ut
 e
qu
al
ly
 c
rit
ic
al
/c
ha
lle
ng
in
g 
ta
sk
s 
w
he
n 
m
an
ag
in
g 
de
pr
es
se
d 
H
IV
 in
fe
ct
ed
 p
at
ie
nt
s.
M
D
D
 o
ft
en
 c
on
tr
ib
ut
es
 t
o 
th
e 
ne
ga
tiv
e 
ps
yc
ho
lo
gi
ca
l e
ffe
ct
s 
of
 H
IV
, 
in
cr
ea
se
s 
em
ot
io
na
l d
is
tr
es
s,
 a
nd
 e
xe
rt
s 
a 
cr
iti
ca
l i
m
pa
ct
 o
n 
ad
he
re
nc
e 
to
 t
re
at
m
en
t 
ov
er
 t
im
e 
in
 H
IV
­
in
fe
ct
ed
 in
di
vi
du
al
s[
45
] . 
C
lin
ic
ia
ns
 e
nc
ou
nt
er
 a
 c
ha
lle
ng
in
g 
ta
sk
 in
 d
ia
gn
os
in
g 
M
D
D
 in
 H
IV
 p
at
ie
nt
s 
gi
ve
n 
th
e 
co
m
pl
ex
 n
at
ur
e 
of
 t
hi
s 
as
so
ci
at
io
n.
 O
ne
 o
f 
th
e 
m
os
t 
de
ba
te
d 
is
su
es
 
is
 w
he
th
er
 o
r 
no
t 
M
D
D
 is
 a
 m
an
ife
st
at
io
n 
of
 H
IV
 b
ra
in
 d
is
or
de
r 
or
, 
co
nv
er
se
ly
, 
M
D
D
 s
ho
ul
d 
be
 c
on
si
de
re
d 
th
e 
pr
im
ar
y 
di
so
rd
er
 t
ha
t 
m
ay
 b
e 
ex
ac
er
ba
te
d 
by
 t
he
 p
re
se
nc
e 
of
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A
tk
in
so
n 
et
 a
l[3
4]
C
ro
ss
-s
ec
tio
na
l 
st
ud
y
20
3 
H
IV
-in
fe
ct
ed
 
fo
rm
er
 p
la
sm
a 
do
no
rs
 a
nd
 1
98
 
H
IV
-n
eg
at
iv
e 
do
no
r c
on
tr
ol
s 
(1
22
 m
al
e,
 2
79
 
fe
m
al
e;
 m
ea
n 
ag
e 
40
.2
 ±
 6
.4
 y
r)
N
o
W
M
H
-C
ID
I, 
BD
I-I
I, 
M
O
S-
H
IV
, M
od
ifi
ed
 
H
IV
 S
tr
es
so
r S
ca
le
, 
A
D
L,
 a
nd
 S
oc
ia
l 
Su
pp
or
t S
ca
le
 
H
IV
+
 s
u
bj
ec
ts
 r
ep
or
te
d
 a
 s
ig
n
ifi
ca
n
tl
y 
h
ig
h
er
 r
at
e 
of
 
lif
et
im
e 
M
D
D
 (1
4%
 v
s 5
%
) t
ha
n 
H
IV
- p
ar
tic
ip
an
ts
. 
Bo
th
 H
IV
+ 
an
d 
H
IV
- r
ep
or
te
d 
si
m
ila
r r
at
es
 o
f c
ur
re
nt
 
M
D
D
. H
IV
+ 
w
er
e 
m
or
e 
lik
el
y 
to
 h
av
e 
lif
et
im
e 
su
bs
ta
nc
e 
us
e 
di
ag
no
se
s 
th
an
 H
IV
- (
14
%
 v
s 6
%
). 
Im
po
rt
an
tly
, w
or
se
 d
ai
ly
 fu
nc
tio
ni
ng
 a
nd
 li
fe
 q
ua
lit
y 
as
 w
el
l a
s 
un
em
pl
oy
m
en
t w
er
e 
in
de
pe
nd
en
tly
 
pr
ed
ic
te
d 
by
 b
ot
h 
de
pr
es
si
on
 a
nd
 A
ID
S
(1
) R
at
es
 o
f d
ep
re
ss
io
n 
m
ay
 b
e 
un
de
re
st
im
at
ed
 b
y 
th
e 
us
ed
 
ps
yc
ho
m
et
ri
c 
m
ea
su
re
s;
 (2
) R
ec
ur
re
nc
e 
of
 M
D
D
 e
pi
so
de
s 
an
d 
bi
po
la
r d
is
or
de
r 
ca
se
s 
ha
ve
 n
ot
 b
ee
n 
ex
am
in
ed
; (
3)
 
Th
e 
sa
m
pl
e 
is
 d
er
iv
ed
 b
y 
an
 a
gr
ar
ia
n 
se
tti
ng
; (
4)
 T
he
 p
re
lim
in
ar
y 
na
tu
re
 o
f 
th
e 
fi
n
d
in
gs
H
ig
h 
lif
et
im
e 
ra
te
s 
of
 M
D
D
 a
nd
 
su
ic
id
al
ity
 w
er
e 
fo
un
d 
in
 th
is
 H
IV
-
in
fe
ct
ed
 a
gr
ar
ia
n 
co
ho
rt
 p
re
su
m
ab
ly
 
du
e 
to
 th
e 
ex
is
te
nc
e 
of
 a
 p
re
-H
IV
 
m
oo
d 
di
so
rd
er
, d
ir
ec
t e
ffe
ct
s 
of
 H
IV
, 
so
ci
al
 s
tig
m
a,
 n
eg
at
iv
e 
im
pa
ct
 o
f 
H
IV
/A
ID
S 
on
 e
m
pl
oy
m
en
t t
og
et
he
r 
w
ith
 th
e 
pe
rc
ep
tio
n 
th
at
 H
IV
 is
 a
 
te
rm
in
al
 c
on
di
tio
n
Sh
er
r e
t a
l[1
1]
C
ro
ss
-s
ec
tio
na
l 
st
ud
y
77
8 
H
IV
-p
os
iti
ve
 
cl
in
ic
 a
tte
nd
er
s 
(1
83
 h
et
er
os
ex
ua
l 
w
om
en
, 7
6 
he
te
ro
se
xu
al
 
m
en
, 4
96
 g
ay
/
bi
se
xu
al
; m
ea
n 
ag
e 
40
.5
 y
r)
N
o
Su
ic
id
al
 id
ea
tio
n 
re
po
rt
ed
 u
si
ng
 a
 s
el
f-
re
po
rt
 it
em
 b
as
ed
 
on
 fe
el
in
gs
 in
 th
e 
pr
ec
ed
in
g 
w
ee
k,
 
le
ve
ls
 o
f o
pt
im
is
m
 in
 
re
la
tio
n 
to
 tr
ea
tm
en
t 
an
d 
in
fe
ct
io
us
ne
ss
, 
M
SA
S 
sh
or
t-f
or
m
, a
nd
 
Eu
ro
Q
ol
-5
D
Su
ic
id
al
 id
ea
tio
n 
w
as
 re
po
rt
ed
 b
y 
31
%
 o
f p
at
ie
nt
s.
 
H
et
er
os
ex
ua
l m
en
 a
nd
 b
la
ck
 re
sp
on
de
nt
s 
w
er
e 
tw
ic
e 
m
or
e 
lik
el
y 
to
 h
av
e 
su
ic
id
al
 id
ea
tio
n 
re
la
tiv
e 
to
 
ga
y 
m
en
 o
r w
om
en
 a
nd
 W
hi
te
/A
si
an
 re
sp
on
de
nt
s,
 
re
sp
ec
tiv
el
y.
 A
ls
o,
 th
os
e 
w
ith
 la
ck
 o
f d
is
cl
os
ur
e 
w
er
e 
tw
ic
e 
m
or
e 
lik
el
y 
to
 h
av
e 
su
ic
id
al
 id
ea
tio
n 
th
an
 
th
os
e 
w
ith
ou
t. 
H
ig
he
r p
hy
si
ca
l a
nd
 p
sy
ch
ol
og
ic
al
 
sy
m
pt
om
s 
in
de
pe
nd
en
tly
 p
re
di
ct
ed
 s
ui
ci
da
l i
de
at
io
n
(1
) T
he
 c
ro
ss
-s
ec
tio
na
l s
tu
dy
 d
es
ig
n;
 
(2
) S
ub
je
ct
s 
ha
ve
 b
ee
n 
no
t e
va
lu
at
ed
 
fo
r t
he
  p
re
se
nc
e 
of
 p
re
vi
ou
s 
su
ic
id
e 
at
te
m
pt
s;
 (3
) P
ar
tic
ip
an
ts
 h
av
e 
be
en
 n
ot
 
te
st
ed
 d
ur
in
g 
a 
fo
llo
w
-u
p 
pe
ri
od
Su
ic
id
al
 id
ea
tio
n 
ra
te
s 
am
on
g 
H
IV
-
po
si
tiv
e 
cl
in
ic
 a
tte
nd
er
s 
w
er
e 
hi
gh
Jin
 et
 a
l[3
5]
C
ro
ss
-s
ec
tio
na
l 
st
ud
y
28
 H
IV
+ 
pa
rt
ic
ip
an
ts
 a
nd
 
23
 m
at
ch
ed
 H
IV
- 
co
nt
ro
ls
 (3
8 
m
al
e,
 
13
 fe
m
al
e;
 m
ea
n 
ag
e 
35
.4
 ±
 6
.7
 y
r)
N
o
C
ID
I D
ep
re
ss
io
n 
M
od
ul
e,
 B
D
I-I
, M
od
ul
e 
E 
of
 th
e 
C
ID
I a
ss
es
si
ng
 
lif
et
im
e 
su
ic
id
al
ity
, 
A
D
L
O
ve
ra
ll,
 7
9%
of
 H
IV
-in
fe
ct
ed
 s
ub
je
ct
s 
ha
d 
a 
lif
et
im
e 
ra
te
 o
f m
aj
or
 d
ep
re
ss
io
n 
re
la
tiv
e 
to
 4
%
 o
f t
he
 
co
m
pa
ri
so
n 
gr
ou
p.
 9
%
 o
f p
at
ie
nt
s 
re
ce
iv
ed
 tr
ea
tm
en
t 
fo
r d
ep
re
ss
io
n,
 b
ut
 1
8%
 s
ho
w
ed
 a
ct
iv
e 
su
ic
id
al
 
th
ou
gh
ts
. W
or
se
 d
ai
ly
 fu
nc
tio
ni
ng
 w
as
 in
de
pe
nd
en
tly
 
pr
ed
ic
te
d 
by
 b
ot
h 
de
pr
es
si
on
 a
nd
 H
IV
+ 
st
at
us
(1
) T
he
 s
m
al
l s
am
pl
e 
si
ze
 th
at
 m
ay
 
lim
it 
th
e 
ge
ne
ra
liz
at
io
n 
of
 th
e 
pr
es
en
t 
fi
n
d
in
gs
; (
2)
 T
h
e 
ef
fe
ct
s 
of
 g
en
d
er
 c
ou
ld
 
be
 n
ot
 s
ep
ar
at
ed
; (
3)
 T
he
 s
am
pl
e 
w
as
 
se
le
ct
ed
 fo
r f
ea
si
bi
lit
y 
pu
rp
os
es
H
ig
h 
ra
te
s 
of
 m
aj
or
 d
ep
re
ss
io
n 
an
d 
su
ic
id
al
ity
 h
av
e 
be
en
 fo
un
d 
in
 H
IV
-
in
fe
ct
ed
 C
hi
ne
se
 s
ub
je
ct
s 
A
D
L:
 A
ct
iv
iti
es
 o
f d
ai
ly
 li
vi
ng
; B
D
I: 
Be
ck
 D
ep
re
ss
io
n 
In
ve
nt
or
y;
 B
H
S:
 B
ec
k 
H
op
el
es
sn
es
s 
Sc
al
e;
 B
D
I-F
S:
 B
ec
k 
D
ep
re
ss
io
n 
In
ve
nt
or
y-
Fa
st
 S
cr
ee
n 
fo
r 
M
ed
ic
al
 P
at
ie
nt
s; 
C
ID
I V
er
si
on
 2
.1
: C
om
po
si
te
 In
te
rn
at
io
na
l D
ia
gn
os
tic
 In
te
rv
ie
w
 
D
ep
re
ss
io
n 
m
od
ul
e;
 D
D
RS
: D
es
ire
 fo
r 
D
ea
th
 R
at
in
g 
Sc
al
e;
 G
A
D
: G
en
er
al
is
ed
 a
nx
ie
ty
 d
is
or
de
r; 
G
SQ
-2
8:
 G
en
er
al
 H
ea
lth
 Q
ue
st
io
nn
ai
re
; G
M
D
S:
 G
ot
la
nd
 M
al
e 
D
ep
re
ss
io
n 
Sc
al
e;
 H
RQ
oL
: H
ea
lth
-r
el
at
ed
 q
ua
lit
y 
of
 li
fe
; M
D
D
: M
aj
or
 
de
pr
es
si
ve
 d
is
or
de
r; 
M
-Q
O
L:
 M
cG
ill
 Q
ua
lit
y 
of
 L
ife
 Q
ue
st
io
nn
ai
re
; M
SA
S:
 M
em
pr
ia
l S
ym
pt
om
 A
ss
es
sm
en
t S
ch
ed
ul
e;
 M
A
C
: M
en
ta
l A
dj
us
tm
en
t t
o 
C
an
ce
r S
ca
le
; M
M
: M
oo
d 
M
od
ul
e;
 M
H
S:
 M
od
er
at
e 
to
 h
ig
h 
ris
k 
fo
r s
ui
ci
da
lit
y;
 M
O
S-
H
IV
: M
ed
ic
al
 O
ut
co
m
es
 S
tu
dy
-H
IV
; P
LW
H
A
: P
eo
pl
e 
liv
in
g 
w
ith
 H
IV
/A
ID
S;
 P
TS
D
: P
os
t-t
ra
um
at
ic
 s
tr
es
s 
di
so
rd
er
; S
A
H
D
: S
ch
ed
ul
e 
of
 A
tti
tu
de
s 
to
w
ar
d 
H
as
te
ne
d 
D
ea
th
; S
F-
36
: S
ho
rt
-F
or
m
 3
6-
Ite
m
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HIV. Interestingly, some authors hypothesized that MDD 
and its clinical presentation should be considered an 
adjustment reaction to the diagnosis of HIV infection[41]. 
Moreover, the presence of depression may significantly 
impair the number and activity of lymphocytes in HIV­
positive patients dramatically reducing the role of 
natural killer cells, which increases the mortality in this 
population[41,42,46]. Del Guerra et al[43] have suggested 
that HIV may predispose patients to the onset of 
MDD through the interaction between the following 
neurobiological mechanisms: (1) Chronic increase of 
inflammatory cytokines and abnormal activation of 
microglia and astrocytes; (2) Consistent reduction of 
monoamine levels; (3) Neurotoxicity; and (4) Reduction 
of neurotrophic factors and subsequent impaired 
neuroplasticity processes, and psychosocial factors.
Our findings indicate a significant association 
between suicide ideation/thoughts and poor quality of life 
in HIV patients[30,36,37,40]. Moreover, results also suggest 
that depression was significantly associated with[38,39] 
or predicted a poor quality of life in HIV patients[34,35]. 
According to population­based studies[47], an higher 
prevalence of suicide in subjects with HIV may be 
found relative to the general population, and comorbid 
mood disorders may be identified in more than half of 
subjects. Among HIV infected individuals, those with 
AIDS were more likely to report current suicidal ideation, 
lifetime suicidal thoughts, and suicide plans compared 
to those without AIDS. This may be explained by the 
fact that individuals diagnosed with AIDS usually have 
a poorer HRQoL than those with HIV infection. Also, the 
presence of severe depressive symptoms in these patients 
was a significant predictor of daily functioning together 
with unemployment, and life quality[34,48]. Moreover, 
depressive symptoms may be independent predictors 
of significant impairment in daily functioning and quality 
of life regardless of the effects of HIV, as suggested by 
Jin et al[35]. The negative consequences of MDD on daily 
functioning and employment have also been found in 
previous studies[49]. Taken together, these findings suggest 
the clinical relevance of early detection and adequate 
MDD treatment, particularly in those individuals who are 
severely medically ill.
The present review should be considered in the light 
of limitations. First, some included studies may reflect 
the authors’ choice according to their expertise and may 
include small sample sizes, which limit the generalization 
of the findings; Second, most studies were cross-sectional 
in nature and did not allow for causal interpretations 
of the associations between depression, quality of life, 
and suicidality in HIV patients; Third, some studies 
predominantly investigated the presence of suicide 
ideation instead of considering the impact of prior suicide 
attempts on the quality of life of HIV patients; Fourth, 
some studies were limited by the possible underestimation 
of MDD and suicidal behavior rates given the use of self­
reported psychometric instruments and the limited power 
of some analyses to find significant differences regarding 
the proportion of patients with depression and suicidality.
The prevalence of depression and suicidal ideation 
are consistent in patients with HIV, suggesting the 
importance of early detection for both these conditions in 
this population. Also, significant associations have been 
reported among MDD, suicidal ideation, and poor quality 
of life in HIV populations. However, further studies are 
necessary to elucidate this complex association.
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